Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis
Sponsor: Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Other Cystic Fibrosis trials with similar outcome
A PHASE4 clinical study on Cystic Fibrosis and Pseudomonas Aeruginosa, this trial is terminated or withdrawn. The trial is conducted by Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche and has accumulated 5 data snapshots since 2001. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2017 — Jan 2021 [monthly]
Terminated PHASE4
First recorded
Oct 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
- Baxter Healthcare Corporation
- GlaxoSmithKline
- Roche Pharma AG
- Vaincre la Mucoviscidose
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Grenoble, France , Lens, France , Lille, France , Marseille, France , Paris, France , Rennes, France , Roscoff, France , Strasbourg, France , Suresnes, France , Toulouse, France and 1 more location